Literature DB >> 28132275

P058. Refractory chronic migraine, fatigue and OnabotulinumtoxinA: a clinic setting experience.

Filippo Baldacci1, Martina Cafalli2, Cinzia Lucchesi2, Sonia Mazzucchi2, Elisa Dini2, Ubaldo Bonuccelli2, Sara Gori2.   

Abstract

Entities:  

Year:  2015        PMID： 28132275      PMCID： PMC4759129          DOI： 10.1186/1129-2377-16-S1-A113

Source DB:  PubMed          Journal:  J Headache Pain        ISSN： 1129-2369            Impact factor:   7.277


× No keyword cloud information.
  2 in total

1.  OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.

Authors:  Sheena K Aurora; Paul Winner; Marshall C Freeman; Egilius L Spierings; Jessica O Heiring; Ronald E DeGryse; Amanda M VanDenburgh; Marissa E Nolan; Catherine C Turkel
Journal:  Headache       Date:  2011-08-29       Impact factor: 5.887

Review 2.  Refractory migraine - a review.

Authors:  Elliott Schulman
Journal:  Headache       Date:  2013-02-13       Impact factor: 5.887
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.